Frontiers in Microbiology (Nov 2022)

Metagenomic next-generation sequencing for identification of central nervous system pathogens in HIV-infected patients

  • Yunqi Zhu,
  • Wenxuan Zhao,
  • Xihong Yang,
  • Yuanyuan Zhang,
  • Xiaoling Lin,
  • Xing Weng,
  • Xing Weng,
  • Yali Wang,
  • Yali Wang,
  • Cong Cheng,
  • Cong Cheng,
  • Yun Chi,
  • Yun Chi,
  • Hongxia Wei,
  • Hongxia Wei,
  • Zhihang Peng,
  • Zhiliang Hu,
  • Zhiliang Hu,
  • Zhiliang Hu

DOI
https://doi.org/10.3389/fmicb.2022.1055996
Journal volume & issue
Vol. 13

Abstract

Read online

Although considerable interest in metagenomic next-generation sequencing (mNGS) has been attracted in recent years, limited data are available regarding the performance of mNGS in HIV-associated central nervous system (CNS) infection. Here, we conducted a retrospectively analyzing of the cerebrospinal fluid (CSF) mNGS reports and other clinical data from 80 HIV-infected patients admitted to the Second Hospital of Nanjing, China from March, 2018 to March, 2022. In our study, CSF mNGS reported negative result, mono-infection, and mixed infection in 8.8, 36.2, and 55% of the patients, respectively. Epstein–Barr virus (EBV), positive in 52.5% of samples, was the most commonly reported pathogen, followed by cytomegalovirus (CMV), John Cunningham virus (JCV), torque teno virus (TTV), cryptococcus neoformans (CN), toxoplasma Gondii (TE), and mycobacterium tuberculosis (MTB). 76.2% of the EBV identification and 54.2% of the CMV identification were not considered clinically important, and relative less sequence reads were reported in the clinical unimportant identifications. The clinical importance of the presence of TTV in CSF was not clear. Detection of JCV, CN, or TE was 100% suggestive of specific CNS infection, however, 60% of the MTB reports were considered contamination. Moreover, of the 44 (55%) mixed infections reported by mNGS, only 4 (5%) were considered clinical important, and mNGS failed to identify one mixed infection. Additionally, except for MTB, CSF mNGS tended to have high sensitivity to identify the above-mentioned pathogens (almost with 100% sensitivity). Even all the diagnostic strategies were evaluated, the cause of neurological symptoms remained undetermined in 6 (7.5%) patients. Overall, our results suggest that mNGS is a very sensitive tool for detecting common opportunistic CNS pathogen in HIV-infected patients, although its performance in CNS tuberculosis is unsatisfactory. EBV and CMV are commonly detected by CSF mNGS, however, the threshold of a clinical important detection remains to be defined.

Keywords